COMMUNIQUÉS West-GlobeNewswire

River Oaks Treatment Center Becomes Veteran Ready Certified, Paving the Way for Enhanced Veteran Addiction Care in Florida

29/10/2024 - 21:46

RIVERVIEW, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) -- River Oaks Treatment Center has become one of a small handful of addiction treatment providers nationwide that have earned the Veteran Ready Certification from [...]

Biomea Fusion Reports Third Quarter 2024 Financial Results and Corporate Highlights

29/10/2024 - 21:46

U.S. Food and Drug Administration (FDA) lifted Clinical Hold on COVALENT-111 (Type 2 Diabetes) & COVALENT-112 (Type 1 Diabetes) trials COVALENT-111 Phase 2b 26-week topline data of the dose expansion cohorts [...]

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024

29/10/2024 - 21:35

BASEL, Switzerland and LONDON and NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, November 12, 2024, to [...]

MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call

29/10/2024 - 21:30

ROCKVILLE, MD, Oct. 29, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based therapeutics for the [...]

Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call

29/10/2024 - 21:30

MALVERN, Pa., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who [...]

Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast

29/10/2024 - 21:22

GARDEN CITY, N.Y., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]

Cronos Group Inc. to Hold 2024 Third Quarter Earnings Conference Call on November 12, 2024

29/10/2024 - 21:15

TORONTO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 third quarter earnings conference call on Tuesday, November 12, 2024 at 8:30 a.m. ET [...]

ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024

29/10/2024 - 21:10

Conference Call Scheduled for November 7, 2024, at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end [...]

Ultragenyx to Host Conference Call for Third Quarter 2024 Financial Results and Corporate Update

29/10/2024 - 21:05

NOVATO, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and [...]

Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024

29/10/2024 - 21:05

SILVER SPRING, Md., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a leader in drug-eluting biomatrix products, today announced that it will release its third quarter 2024 [...]

Exagen to Announce Third Quarter 2024 Results on November 12, 2024

29/10/2024 - 21:05

CARLSBAD, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended September 30, 2024, before the market opens [...]

OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024

29/10/2024 - 21:05

MIAMI, Oct. 29, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and nine months ended September 30, 2024 after the close of the U.S. financial [...]

CVRx Reports Third Quarter 2024 Financial and Operating Results

29/10/2024 - 21:05

MINNEAPOLIS, Oct. 29, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]

Clover Health to Participate in Upcoming Investor Conferences

29/10/2024 - 21:05

FRANKLIN, Tenn., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following investor conferences: [...]

Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024

29/10/2024 - 21:05

FREMONT, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the third quarter 2024 after [...]

BioVie Inc. Announces Closing of Registered Direct Offering

29/10/2024 - 21:05

CARSON CITY, Nev., Oct. 29, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (Nasdaq: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions [...]

The Ensign Group Announces Expansion in Tennessee, Agrees to Add Its First Operation in Alabama

29/10/2024 - 21:05

SAN JUAN CAPISTRANO, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign TM group of companies, which invest in and provide skilled nursing and senior living [...]

Shuttle Pharma Pays Off Senior Secured Convertible Note

29/10/2024 - 21:05

GAITHERSBURG, Md., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving [...]

Stryker reports third quarter 2024 operating results

29/10/2024 - 21:05

Portage, Michigan, Oct. 29, 2024 (GLOBE NEWSWIRE) -- reported operating results for the third quarter of 2024 : Third Quarter Results Reported net sales increased 11.9% to $5.5 billion Organic net sales increased 11.5% [...]